IP Library › Granted Patent US 10,821,205
Granted Patent B2
US 10,821,205 · App. 16/164,177 · Granted Nov 3, 2020

Adipose tissue products and methods of production

Inventors: Hui Xu (Plainsboro, NJ); Carrie Fang (Madison, NJ); Mrinal Shah (Parsippany, NJ); Israel James Jessop (Annandale, NJ)
Assignee: LifeCell Corporation
A61L27/3691A61L27/24A61L27/3604A61L27/3633A61L27/3683A61L27/3687A61L27/48A61L27/56A61L27/58A61L2400/06A61L2430/04A61L2430/34A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,821,205
App. No.
16/164,177
Granted
Nov 3, 2020
Kind
B2
Abstract

Compositions and methods for treating tissue are provided. The compositions may include tissue matrix derived from adipose tissue suitable for injection, small-volume implantation, or use as a soft-tissue regenerative material. Also provided are methods for producing such compositions.

Claims (25)

1. A method for producing a tissue product, comprising:

selecting an adipose tissue;

mechanically processing the adipose tissue to reduce the tissue size;

treating the mechanically processed tissue to remove substantially all cellular material from the tissue;

suspending the tissue in a solution to form a suspension;

treating the suspension to produce a stabilized three-dimensional structure with a micro-porous structure; and

mechanically processing the stabilized three-dimensional structure to produce particles.

2. The method of claim 1 , wherein treating the suspension to produce a stabilized three-dimensional structure includes drying the suspension.

3. The method of claim 2 , wherein drying includes freeze-drying.

4. The method of claim 1 , wherein treating the suspension to produce a stabilized three-dimensional structure includes cross-linking the tissue.

5. The method of claim 4 , wherein cross-linking includes treatment with at least one of a chemical, a photo-activated cross-linking process, or heating.

6. The method of claim 5 , wherein the chemical includes at least one of glutaraldehyde, genepin, carbodiimides, and diisocyantes.

7. The method of claim 4 , wherein cross-linking includes heating the tissue.

8. The method of claim 7 , wherein the tissue is heated in a vacuum.

9. The method of claim 4 , wherein the tissue is heated to 70° C. to 120° C.

10. The method of claim 1 , wherein the stabilized three-dimensional structure maintains its micro-porous structure when in contact with an aqueous environment.

11. The method of claim 10 , wherein the material maintains the stable three-dimensional structure when implanted in a body.

12. The method of claim 1 , wherein mechanically processing the stabilized three-dimensional structure to produce particles includes producing a group of particles comprising a longest dimension between 50 microns to 4 mm.

13. The method of claim 1 , wherein mechanically processing the stabilized three-dimensional structure to produce particles includes producing a group of particles comprising a longest dimension between 1.5 mm to 4 mm.

14. The method of claim 1 , wherein mechanically processing the stabilized three-dimensional structure to produce particles includes producing a group of particles comprising a longest dimension between 2 mm to 3.5 mm.

15. The method of claim 1 , wherein mechanically processing the stabilized three-dimensional structure to produce particles includes producing a group of particles comprising a longest dimension between 2 mm to 3 mm.

16. The method of claim 1 , wherein mechanically processing the stabilized three-dimensional structure to produce particles includes producing a group of particles having a micro-porous structure retained from the stabilized three-dimensional structure.

17. The method of claim 1 , further comprising hydrating the particles.

18. The method of claim 17 , wherein hydrating the particles includes combining the particles with a mass of an aqueous solution such that the particles and aqueous solution form a composition that is between 5% and 20% particles by weight.

19. The method of claim 18 , wherein hydrating the particles includes combining the particles with a mass of an aqueous solution such that the particles and aqueous solution form a composition that is between 5% and 12% particles by weight.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: XU, HUI; FANG, CARRIE; SHAH, MRINAL; JESSOP, ISRAEL JAMES
To: LIFECELL CORPORATION
Reel/Frame 047690/0214 →
Continuity (2)
Provisional Application 62573892 · Oct 18, 2017
Related Publication 20190111183A1 · Apr 18, 2019
Cited By (3)
US 12,351,620 US 12,351,621 US 12,741,051